MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select ...
Hosted on MSN
PacBio (NASDAQ:PACB) reports strong Q4 CY2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results , with sales up 13.8% year on year to $44.65 million. Its non-GAAP loss of $0.12 per share was 10.8% above ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results